Form 4: Dave Inc. CEO Sells Shares Under 10b5-1 Plan

Dave Inc. CEO Jason Wilk reported the sale of 18,307 Class A Common Stock shares for approximately $4.21 million under a pre-arranged 10b5-1 trading plan.

Summary

• Jason Wilk, Chief Executive Officer and Director of Dave Inc. (DAVE), reported transactions involving Class A Common Stock and Class V Common Stock.
• On September 12, 2025, Wilk acquired 15,359 shares of Class A Common Stock upon conversion of Class V Common Stock at an exercise price of $0.
• Concurrently on September 12, 2025, Wilk sold 15,359 shares of Class A Common Stock at a weighted average price of $230.01 per share, with prices ranging from $230.00 to $230.33.
• On September 15, 2025, Wilk acquired 2,948 shares of Class A Common Stock upon conversion of Class V Common Stock at an exercise price of $0.
• Concurrently on September 15, 2025, Wilk sold 2,948 shares of Class A Common Stock at a weighted average price of $230.01 per share, with prices ranging from $230.00 to $230.17.
• The total number of Class A Common Stock shares sold across both dates was 18,307, generating approximately $4,210,803.07.
• All sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Wilk on May 30, 2025.
• Following these transactions, Wilk directly beneficially owns 217,854 shares of Class A Common Stock and indirectly owns 47,882 shares of Class A Common Stock through a Trust, totaling 265,736 Class A Common Stock shares.
• Wilk also directly beneficially owns 1,395,775 shares of Class V Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The transactions represent routine insider sales executed under a pre-arranged Rule 10b5-1 trading plan, which is a common practice for executives to manage personal finances and is generally not indicative of a change in the company's fundamental outlook.

Positives

• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating planned liquidity rather than a reaction to recent events, which can reduce negative market perception of insider selling.
• The sale price of $230.01 per share reflects a significant valuation for the company's stock.

Negatives

• The sale of shares by a key executive, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it reduces the insider's direct equity stake.

Risks

• No specific risks were mentioned in the filing beyond the general implications of insider selling.

Future Outlook

The filing does not contain any specific forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The sales reported were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2025.

Industry Context

This Form 4 filing is a standard regulatory disclosure for insider transactions. Such planned sales under Rule 10b5-1 are common across publicly traded companies, particularly for executives managing personal liquidity and diversification, and are generally viewed as routine within the financial services and technology sectors where Dave Inc. operates.

Comparison to Industry Standards

• The execution of sales under a Rule 10b5-1 plan is a widely accepted practice for corporate insiders to manage their equity holdings while avoiding accusations of trading on material non-public information. This aligns with best practices for corporate governance and transparency in insider transactions.

Stakeholder Impact

• Shareholders: May observe a reduction in the CEO's direct equity stake, but the 10b5-1 plan mitigates concerns about opportunistic selling. The high sale price could be seen as a positive indicator of valuation.
• Regulatory Authorities: The filing demonstrates compliance with Section 16(a) of the Securities Exchange Act of 1934 and Rule 10b5-1.

Next Steps

• No specific future actions, events, or milestones are mentioned in this filing.

Key Dates

Recommendation

The reported transactions are routine insider sales executed under a pre-arranged Rule 10b5-1 trading plan. Such planned sales are generally not indicative of a change in management's outlook on the company's future prospects and therefore do not typically warrant a change in investment recommendation based solely on this filing. Investors should consider broader company fundamentals and market conditions.

Keywords

Dave Inc., DAVE, Jason Wilk, Insider Trading, Form 4, 10b5-1 Plan, Stock Sale, CEO, Equity Transaction, Class A Common Stock, Class V Common Stock